6'-Bromo-8'-methyl-2'H-spiro[cyclohexane-1,3'-imidazo[1,5-a]pyridine]-1',5'-dione
98%
- Product Code: 152962
CAS:
1849592-70-6
Molecular Weight: | Molecular Formula: | ||
---|---|---|---|
EC Number: | MDL Number: | ||
Melting Point: | Boiling Point: | ||
Density: | Storage Condition: | 2-8°C, dry |
Product Description:
Used as a key intermediate in the synthesis of pharmaceutical compounds, particularly in the development of kinase inhibitors for cancer treatment. Its spirocyclic structure enhances binding selectivity and metabolic stability in drug candidates. Commonly employed in medicinal chemistry research to optimize lead compounds targeting neurological disorders and inflammatory diseases. Also utilized in the preparation of novel imidazopyridine derivatives for evaluating biological activity in preclinical studies.
Sizes / Availability / Pricing:
Size | Availability | Price | Quantity |
---|---|---|---|
100mg | 10-20 days | $1,902.81 |
+
-
|
250mg | 10-20 days | $3,256.73 |
+
-
|
1g | 10-20 days | $8,850.65 |
+
-
|
6'-Bromo-8'-methyl-2'H-spiro[cyclohexane-1,3'-imidazo[1,5-a]pyridine]-1',5'-dione
Used as a key intermediate in the synthesis of pharmaceutical compounds, particularly in the development of kinase inhibitors for cancer treatment. Its spirocyclic structure enhances binding selectivity and metabolic stability in drug candidates. Commonly employed in medicinal chemistry research to optimize lead compounds targeting neurological disorders and inflammatory diseases. Also utilized in the preparation of novel imidazopyridine derivatives for evaluating biological activity in preclinical studies.
Mechanism | - |
Appearance | - |
Longevity | - |
Strength | - |
Storage | - |
Shelf Life | - |
Allergen(s) | - |
Dosage (Range) | - |
Recommended Dosage | - |
Dosage (Per Day) | - |
Recommended Dosage (Per Day) | - |
Mix Method | - |
Heat Resistance | - |
Stable in pH range | - |
Solubility | - |
Product Types | - |
INCI | - |
Purchase History for
Loading purchase history...
Cart
No products
Subtotal:
$0.00
$0.00
Total :